Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HF.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HF.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HF.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HF.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HF.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HF.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.22ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.22ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.22EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.22EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FW.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FW.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FW.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FW.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FW.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FW.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FW.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JR.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JR.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JR.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JR.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JR.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JR.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JR.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JR.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JD.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JD.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JD.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JD.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.3.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JG.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JG.3.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JG.3.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JG.3.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JG.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
KE.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KE.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KE.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used